Skip to content

Item 9 Labs Corp.

company.status.inactive

CIK 1500123fmd_1AX448G6TRZKBMYNA74NHWYQ4SManufacturing · Dental Equipment & SuppliesTemplate: Standard

Coverage: Oct 01, 2009 to Jun 30, 2023, 46 periods

Latest annual · FY2022

Millions
Total revenues
22
Gross profit
7
Operating income
(23)
Net income
(31)
Free cash flow
(7)

Latest quarter · Q3 FY2023

Millions
Total revenues
5
Gross profit
3
Operating income
(3)
Net income
(6)
Free cash flow
0
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2019 to FY2022
+64.0%
Revenue, 5 yearsFY2015 to FY2022
+186.3%
Net income, 5 yearsFY2015 to FY2022
n/m

Item 9 Labs Corp. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2022FY2021ChangeSource
Revenue$21.8 million$21.9 million-0.8%10-K 2023-01-13 · proof
Gross profit$7.3 million$8.6 million-15.1%10-K 2023-01-13 · proof
Operating income-$23.1 million-$5.6 million10-K 2023-01-13 · proof
Net income-$31.2 million-$10.9 million10-K 2023-01-13 · proof
Cash from operating activities-$2.3 million-$6 million10-K 2023-01-13 · proof
Free cash flow-$6.6 million-$8.2 million10-K 2023-01-13 · proof
Total assets$110.8 million$116.8 million-5.2%10-K 2023-01-13 · proof
Total liabilities$48.8 million$30.7 million+59%10-K 2023-01-13 · proof
Cash and cash equivalents$85,637$1.5 million-94.1%10-K 2023-01-13 · proof
What was Item 9 Labs Corp.'s revenue in fiscal 2022?
Item 9 Labs Corp. reported revenue of $21.8 million for fiscal 2022 (the year ended Sep 30, 2022), against $21.9 million the year before (-0.8%). Source: the 10-K filed with the SEC on Jan 13, 2023. SEC
What was Item 9 Labs Corp.'s gross profit in fiscal 2022?
Item 9 Labs Corp. reported gross profit of $7.3 million for fiscal 2022 (the year ended Sep 30, 2022), against $8.6 million the year before (-15.1%). Source: the 10-K filed with the SEC on Jan 13, 2023. SEC
What was Item 9 Labs Corp.'s operating income in fiscal 2022?
Item 9 Labs Corp. reported operating income of -$23.1 million for fiscal 2022 (the year ended Sep 30, 2022), against -$5.6 million the year before. Source: the 10-K filed with the SEC on Jan 13, 2023. SEC
What was Item 9 Labs Corp.'s net income in fiscal 2022?
Item 9 Labs Corp. reported net income of -$31.2 million for fiscal 2022 (the year ended Sep 30, 2022), against -$10.9 million the year before. Source: the 10-K filed with the SEC on Jan 13, 2023. SEC
What was Item 9 Labs Corp.'s cash from operating activities in fiscal 2022?
Item 9 Labs Corp. reported cash from operating activities of -$2.3 million for fiscal 2022 (the year ended Sep 30, 2022), against -$6 million the year before. Source: the 10-K filed with the SEC on Jan 13, 2023. SEC
What was Item 9 Labs Corp.'s free cash flow in fiscal 2022?
Item 9 Labs Corp. reported free cash flow of -$6.6 million for fiscal 2022 (the year ended Sep 30, 2022), against -$8.2 million the year before. Source: the 10-K filed with the SEC on Jan 13, 2023. SEC
What are Item 9 Labs Corp.'s total assets?
As of Sep 30, 2022, Item 9 Labs Corp. reported total assets of $110.8 million, against $116.8 million a year earlier (-5.2%). Source: the 10-K filed with the SEC on Jan 13, 2023. SEC
What are Item 9 Labs Corp.'s total liabilities?
As of Sep 30, 2022, Item 9 Labs Corp. reported total liabilities of $48.8 million, against $30.7 million a year earlier (+59%). Source: the 10-K filed with the SEC on Jan 13, 2023. SEC
What are Item 9 Labs Corp.'s cash and cash equivalents?
As of Sep 30, 2022, Item 9 Labs Corp. reported cash and cash equivalents of $85,637, against $1.5 million a year earlier (-94.1%). Source: the 10-K filed with the SEC on Jan 13, 2023. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1500123&period_type=annual&limit=5"

Information only, not investment advice.